close
Open Access, Peer-reviewed
pISSN 3092-278X   eISSN 3092-3018
Current Issue      April 2026 • vol. 1 no. 2
Review Article
What Should Be the Definition of “Remission” in Pulmonary Arterial Hypertension?
Miyagi A, Kuronuma K, Shimokawahara H, Matsubara H.
https://doi.org/10.65721/rhj.2026.1.e11
Review Article
Cancer Therapy-Related Pulmonary Hypertension: Implicated Agents, Diagnostic Considerations, and Management Strategies
Park H, Lee N, Kim KH.
https://doi.org/10.65721/rhj.2026.1.e13
Original Article
Real-World Experience With Sotatercept in Pulmonary Arterial Hypertension: Hematologic Effects and Safety Considerations
Chan CC, Wu S, Poch DS, Fernandes TM, Papamatheakis DG, Kim NH, Yang JZ.
https://doi.org/10.65721/rhj.2026.1.e10
Editorial
Sotatercept in the Real World: Hematologic Monitoring an Integral Component
Gwak SY, Na JO.
https://doi.org/10.65721/rhj.2026.1.e14
Original Article
Left Atrial Compliance as a Key Determinant of Hemodynamic Phenotypes in HFpEF Patients With Pulmonary Hypertension: Rationale and Study Design
Kim BJ, Kim SJ, Im SI, Heo JH.
https://doi.org/10.65721/rhj.2026.1.e12
Editorial
Left Atrial Compliance as the Hemodynamic Bridge Between Heart Failure and Pulmonary Hypertension
Kim HJ.
https://doi.org/10.65721/rhj.2026.1.e15
Forthcoming Articles
>
Past Issues
>
Submit Your
Manuscript to RHJ
Editorial Manager®      
  
RHJ on
Society affiliation and support of APC
Right Heart Journal is the official journal of the Korean Society of Pulmonary Hypertension (KSPH), the Japanese Pulmonary Circulation and Pulmonary Hypertension Society (JPCPHS), the Taiwan Pulmonary Hypertension Association (TPHA), the China Pulmonary Hypertension Group (CPHG) and the East Asia Society of Pulmonary Hypertension (EASOPH).
These societies support full amount of APC for all the articles accepted for publication so that the authors do not need to pay.